proxyvotesnow.com

Home › Companies › CORE LABORATORIES INC. › 2024-2025

CORE LABORATORIES INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and CORE LABORATORIES INC.’s Form 8-K, filed 2025-05-27 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 5Ballot items
  • 260Asset managers
  • 1,371Fund votes
  • 2025-05-21Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore CORE LABORATORIES INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by CORE LABORATORIES INC.

These tallies are CORE LABORATORIES INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-27 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

CORE LABORATORIES INC. — official shareholder meeting results, meeting held 2025-05-21
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Martha Z. Carnes 37,510,862---- 2,818,7292,182,232 Majority: yes
Elect Director: Katherine Murray 39,747,197---- 582,3942,182,232 Majority: yes
Elect Director: Rob Martinovich 38,894,796---- 1,434,7952,182,232 Majority: yes
Proposal 2: Appointment of KPMG as Independent Registered Public Accountant : The ratification of the appointment of KPMG as the Company's independent registered public accountant for the fiscal year ending December 31, 2025, was approved as follows: 41,812,461685,31114,051 ---- Majority: yes
Proposal 3: Approving the Compensation of the Company's Named Executive Officers : An advisory vote on the compensation of the Company's named executive officers was approved as follows: 38,010,4042,292,67526,512 --2,182,232 Majority: yes

Source: CORE LABORATORIES INC., Form 8-K, filed with the SEC on 2025-05-27 — read the filing on EDGAR.

How asset managers voted at the CORE LABORATORIES INC. 2024-2025 meeting

Each item below shows how the 260 asset managers that disclosed a CORE LABORATORIES INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the section entitled Compensation Discussion and Analysis ("CD&A"), and the compensation of the Company's named executive officers as disclosed pursuant to the U.S. Securities and Exchange Commission's compensation disclosure rules, including the compensation tables.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 16 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 38,010,404AGAINST: 2,292,675

CORE LABORATORIES INC.’s own tally for this item (“Proposal 3: Approving the Compensation of the Company's Named Executive Officers : An advisory vote on the compensation of the Company's named executive officers was approved as follows:”): 38,010,404 for, 2,292,675 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,882,935 outstanding shares: 81% for, 5% against (86% of the company cast a for/against vote).

The 257 asset managers below cast 95% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 95%
FOR: 94.6%AGAINST: 5.4%ABSTAIN: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “To approve, on an advisory basis, the compensation philosophy, policies and procedures described in the sectio” at CORE LABORATORIES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,854,2383 00For
ARIEL INVESTMENT TRUST5,260,3860 00For
DISCIPLINED GROWTH INVESTORS INC /MN4,761,0240 00For
BlackRock4,454,12088,217 00For
ARIEL INVESTMENTS, LLC3,917,2220 00For
EARNEST PARTNERS LLC2,583,8986,934 00For
HARBOR FUNDS1,432,8250 00For
State Street1,324,029148 00For
T. Rowe Price1,142,4760 00For
Royce963,7540 00For
Charles Schwab933,2190 00For
BOSTON TRUST WALDEN FUNDS0518,522 00Against
Northern Trust477,9510 00For
GENDELL JEFFREY L456,9960 00For
WEATHERBIE CAPITAL, LLC0448,427 00Against
Elevation Series Trust368,0440 00For
Fisher Asset Management, LLC79,952251,358 00Against
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC283,9900 00For
Dimensional272,0800 00For
PRINCIPAL GLOBAL INVESTORS234,1320 00For
PARAMETRIC PORTFOLIO ASSOCIATES LLC232,4920 00For
American Century232,0280 00For
Russell Investments231,8390 00For
MELLON INVESTMENTS Corp209,1150 00For
EAGLE ASSET MANAGEMENT INC197,7930 00For

Showing the 25 largest of 257 asset managers. See all 257 in the interactive database.

2. To elect one new Class II Director and re-elect two current Class II Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2028 and until their successors shall have been duly elected and qualified: Martha Z. Carnes

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%
FOR: 37,510,862WITHHELD: 2,818,729

CORE LABORATORIES INC.’s own tally for this item (“Elect Director: Martha Z. Carnes”): 37,510,862 for, 2,818,729 withheld, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,882,935 outstanding shares: 80% for, 6% withheld (86% of the company cast a for/withheld vote).

The 69 asset managers below cast 100% of the shares they voted on this item FOR (20,367,124 for, 0 against).

FOR 99%
FOR: 20,367,124 (98.6%)ABSTAIN: 287,146 (1.4%)
Largest asset managers voting on “To elect one new Class II Director and re-elect two current Class II Directors to serve under the terms and co” at CORE LABORATORIES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,707,3250 1,7540For
ARIEL INVESTMENT TRUST5,260,3860 00For
BlackRock3,233,3840 00For
HARBOR FUNDS1,432,8250 00For
Royce956,8740 00For
BOSTON TRUST WALDEN FUNDS518,5220 00For
Charles Schwab436,3790 00For
Elevation Series Trust368,0440 00For
State Street274,9230 00For
Bridge Builder Trust193,7000 00For
ALGER FUNDS186,3100 00For
Dimensional182,7790 00For
Columbia Threadneedle173,0390 00For
TIAA125,6930 00For
Equitable74,4540 48,3000For
American Century116,0140 00For
WisdomTree112,3580 00For
Fidelity111,5060 00For
Principal108,7810 00For
HOTCHKIS & WILEY FUNDS /DE/102,6000 00For
Jackson National94,5660 00For
VanEck ETF Trust00 91,6440Abstain
Russell Investments00 83,4010Abstain
First Trust70,1190 00For
Empower59,3350 00For

Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.

3. To elect one new Class II Director and re-elect two current Class II Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2028 and until their successors shall have been duly elected and qualified: Katherine Murray

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 39,747,197WITHHELD: 582,394

CORE LABORATORIES INC.’s own tally for this item (“Elect Director: Katherine Murray”): 39,747,197 for, 582,394 withheld, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,882,935 outstanding shares: 85% for, 1% withheld (86% of the company cast a for/withheld vote).

The 69 asset managers below cast 100% of the shares they voted on this item FOR (20,600,078 for, 0 against).

FOR 99.7%
FOR: 20,600,078 (99.7%)ABSTAIN: 54,191 (0.3%)
Largest asset managers voting on “To elect one new Class II Director and re-elect two current Class II Directors to serve under the terms and co” at CORE LABORATORIES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,709,0780 00For
ARIEL INVESTMENT TRUST5,260,3860 00For
BlackRock3,233,3840 00For
HARBOR FUNDS1,432,8250 00For
Royce956,8740 00For
BOSTON TRUST WALDEN FUNDS518,5220 00For
Charles Schwab436,3790 00For
Elevation Series Trust368,0440 00For
State Street274,9230 00For
Bridge Builder Trust193,7000 00For
ALGER FUNDS186,3100 00For
Dimensional182,7790 00For
Columbia Threadneedle173,0390 00For
TIAA125,6930 00For
Equitable74,4540 48,3000For
American Century116,0140 00For
WisdomTree112,3580 00For
Fidelity111,5060 00For
Principal108,7810 00For
HOTCHKIS & WILEY FUNDS /DE/102,6000 00For
Jackson National94,5660 00For
VanEck ETF Trust91,6440 00For
Russell Investments83,4010 00For
First Trust70,1190 00For
Empower59,3350 00For

Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.

4. To elect one new Class II Director and re-elect two current Class II Directors to serve under the terms and conditions described within the proxy statement until our annual meeting in 2028 and until their successors shall have been duly elected and qualified: Rob Martinovich

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 3 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 38,894,796WITHHELD: 1,434,795

CORE LABORATORIES INC.’s own tally for this item (“Elect Director: Rob Martinovich”): 38,894,796 for, 1,434,795 withheld, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,882,935 outstanding shares: 83% for, 3% withheld (86% of the company cast a for/withheld vote).

The 69 asset managers below cast 100% of the shares they voted on this item FOR (20,652,081 for, 0 against).

FOR 99.9%
FOR: 20,652,081 (100.0%)ABSTAIN: 2,189 (0.0%)
Largest asset managers voting on “To elect one new Class II Director and re-elect two current Class II Directors to serve under the terms and co” at CORE LABORATORIES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,709,0790 00For
ARIEL INVESTMENT TRUST5,260,3860 00For
BlackRock3,233,3840 00For
HARBOR FUNDS1,432,8250 00For
Royce956,8740 00For
BOSTON TRUST WALDEN FUNDS518,5220 00For
Charles Schwab436,3790 00For
Elevation Series Trust368,0440 00For
State Street274,9230 00For
Bridge Builder Trust193,7000 00For
ALGER FUNDS186,3100 00For
Dimensional182,7790 00For
Columbia Threadneedle173,0390 00For
TIAA125,6930 00For
Equitable122,7540 00For
American Century116,0140 00For
WisdomTree112,3580 00For
Fidelity111,5060 00For
Principal108,7810 00For
HOTCHKIS & WILEY FUNDS /DE/102,6000 00For
Jackson National94,5660 00For
VanEck ETF Trust91,6440 00For
Russell Investments83,4010 00For
First Trust70,1190 00For
Empower59,3350 00For

Showing the 25 largest of 69 asset managers. See all 69 in the interactive database.

5. To ratify the appointment of KPMG LLP as the Company's independent registered public accountants for the year ending December 31, 2025; and

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 41,812,461AGAINST: 685,311

CORE LABORATORIES INC.’s own tally for this item (“Proposal 2: Appointment of KPMG as Independent Registered Public Accountant : The ratification of the appointment of KPMG as the Company's independent registered public accountant for the fiscal year ending December 31, ”): 41,812,461 for, 685,311 against, per its Form 8-K filed 2025-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 46,882,935 outstanding shares: 89% for, 1% against (91% of the company cast a for/against vote).

The 68 asset managers below cast 99.8% of the shares they voted on this item FOR (20,569,557 for, 24,148 against).

FOR 99.8%
FOR: 20,569,557 (99.9%)AGAINST: 24,148 (0.1%)ABSTAIN: 1,230 (0.0%)
Largest asset managers voting on “To ratify the appointment of KPMG LLP as the Company's independent registered public accountants for the year ” at CORE LABORATORIES INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard5,709,0781 00For
ARIEL INVESTMENT TRUST5,260,3860 00For
BlackRock3,233,3840 00For
HARBOR FUNDS1,432,8250 00For
Royce956,8740 00For
BOSTON TRUST WALDEN FUNDS518,5220 00For
Charles Schwab436,3790 00For
Elevation Series Trust368,0440 00For
State Street274,90320 00For
Bridge Builder Trust193,7000 00For
ALGER FUNDS186,3100 00For
Dimensional182,7790 00For
Columbia Threadneedle173,0390 00For
TIAA125,6930 00For
Equitable122,7540 00For
American Century116,0140 00For
WisdomTree112,3580 00For
Fidelity111,5060 00For
Principal108,7810 00For
HOTCHKIS & WILEY FUNDS /DE/102,6000 00For
Jackson National94,5660 00For
VanEck ETF Trust91,6440 00For
Russell Investments83,4010 00For
First Trust70,1190 00For
BNY Mellon51,5940 00For

Showing the 25 largest of 68 asset managers. See all 68 in the interactive database.

Largest CORE LABORATORIES INC. shareholders voting in 2024-2025

Ranked by the number of CORE LABORATORIES INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 46,882,935 shares outstanding at the time of that meeting.

Top CORE LABORATORIES INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1Vanguard 12.49%
2ARIEL INVESTMENT TRUST 11.22%
3DISCIPLINED GROWTH INVESTORS INC /MN 10.16%
4BlackRock 9.69%
5ARIEL INVESTMENTS, LLC 8.36%
6EARNEST PARTNERS LLC 5.53%
7HARBOR FUNDS 3.06%
8State Street 2.82%
9T. Rowe Price 2.44%
10Royce 2.06%

Reported CORE LABORATORIES INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

CORE LABORATORIES INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Ariel Investments, LLC 29.38% 13G
BlackRock 16.01% 13F
Vanguard Group 11.55% 13F
DISCIPLINED GROWTH INVESTORS INC /MN 10.53% 13G
EARNEST PARTNERS LLC 6.87% 13G
State Street 4.13% 13F
Geode Capital 2.31% 13F
Dimensional Fund Advisors 2.07% 13F
Morgan Stanley 1.26% 13F
Northern Trust 1.13% 13F

Percentages above are of 46,882,935 shares outstanding, as reported by CORE LABORATORIES INC. on its Form 10-Q dated 2025-04-18 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CORE LABORATORIES INC.’s 10-Q dated 2025-04-18. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At CORE LABORATORIES INC.'s shareholder meeting held 2025-05-21, in the 2024-2025 proxy season, 260 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,371 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation philosophy, policies and procedures… — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CORE LABORATORIES INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-27.

CORE LABORATORIES INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.